Observed Signal · Jun 25, 2026 · Hiring · Source: The Drum · Impact: 2/5 · Sentiment: Positive
Former Trade Desk CMO Joins DeepIntent
Ian Colley, former chief marketing officer of The Trade Desk, left TTD in April and has joined healthcare-specialist DSP DeepIntent as its CMO. Colley says he chose DeepIntent because healthcare programmatic advertising can drive commercial insights that help bring treatments to market. The article notes The Trade Desk faced a Publicis-commissioned audit and client warnings in March that later led to a joint statement and Publicis re-adding TTD to its approved vendor list. DeepIntent, a US-focused DSP with roughly 400 employees, has launched products including a cloud platform called Helix AI and aims to evolve from a DSP into a planning platform for big pharma using agentic AI.
Talent movement from a high-profile DSP to a specialist healthcare DSP signals strategic focus and product ambition (AI-driven pharma planning) within a niche of programmatic advertising, but it is not industry-shifting.
Track DeepIntent Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your free Explorer workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- Ian Colley left The Trade Desk earlier in 2026 and joined DeepIntent as its chief marketing officer.
- DeepIntent is described as a healthcare-specialist DSP operating (for now) exclusively in the US and with a headcount of about 400.
- The Trade Desk faced a March 2026 dispute after a Publicis-commissioned audit prompted Publicis Groupe to advise clients against using TTD; TTD denied the claims and later issued a joint statement with Publicis, after which Publicis re-added TTD to its approved vendor list.
- DeepIntent has launched a cloud product called Helix AI and stated ambitions to become more than a DSP — positioning itself as a future planning platform for big pharma using agentic AI.
Connected Companies & Entities
5 Entities mapped“it’s as CMO not of The Trade Desk but of healthcare-specialist DSP DeepIntent, with its modest-but-growing headcount of not 400,000 or 4,000...”
“Since then, TTD has grown to become one of the most visible brands in the crowded DSP space, itself clocking in at about 4,000 workers....”
“Ian Colley cut his teeth at IBM, the IT behemoth that at the time employed close to 400,000 people worldwide....”
“In March, Publicis Groupe advised clients against using TTD after a Publicis-commissioned audit alleged hidden fees and a lack of transparen...”
“the dispute prompted rival holding company Omnicom to commission its own external audit and triggered a sharp dip in TTD’s share price....”
Ontology Mapping & Concepts
Related Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
Ian Colley Named DeepIntent Chief Marketing Officer
DeepIntent has appointed Ian Colley — most recently CMO of The Trade Desk — as its new chief marketing officer, effective late April 2026. Colley will oversee marketing and communications at the healthcare-focused demand-side platform and report to founder and CEO Chris Paquette. He succeeds Adam Kapel, who left DeepIntent in 2024. Colley brings more than three decades of marketing and communications experience, including seven years at The Trade Desk and earlier roles at IBM. The hire comes as the U.S. government weighs potential restrictions on pharmaceutical advertising that could affect more than $10 billion in annual ad spending.
DeepIntent launches agentic ad platform Cora for pharma marketing
DeepIntent, a healthcare-focused adtech firm, has launched Cora, an AI-powered agentic advertising platform designed for pharmaceutical marketers. The platform uses multiple AI agents to handle campaign planning, audience strategy, and media execution, including linear TV via a VideoAmp integration. Cora aims to speed up marketing workflows, with beta tests showing a 50% reduction in planning cycles and over 95% of clients reporting faster processes. This launch follows DeepIntent's majority stake sale to Vitruvian Partners, which provided $637 million to develop AI tools. The company targets the growing complexity of pharma marketing, especially for niche drugs targeting small patient populations. Cora is also powered by Helix, a data application providing aggregated healthcare data, including payer signals and drug coverage insights.
Trade Desk Faces Programmatic Power Struggle
Major agencies including Dentsu and WPP have pulled back spend from The Trade Desk’s OpenPath offering amid concerns about hidden fees and transparency; Publicis Groupe stopped recommending TTD after a third-party audit. The Trade Desk is also changing how it pays identity providers such as LiveRamp and Experian. The episode frames the dispute as part of a broader industry shift in which DSPs, SSPs and agency holding companies vie to become a single unified ad platform (UAP). Competitors named include Pubmatic, Magnite and Index. The Trade Desk has seen executive departures (including Melinda Zurich, Matthew Henick and Ian Colley) and a stock decline this year, but posted nearly $3 billion in revenue last year and continues pushing direct-to-brand/publisher strategies via OpenPath and its AI-driven Kokai platform.
Track Real-Time Market Signals & Shifts
Set up custom watchlists to receive automated, evidence-grounded executive digests whenever material signals or shifts occur across your tracked landscape.